Me. Garay-sevilla et al., Denial of disease in Type 2 diabetes mellitus: its influence on metabolic control and associated factors, DIABET MED, 16(3), 1999, pp. 238-244
Aims We have investigated denial of disease in patients with Type 2 diabete
s mellitus (DM) and its possible association with metabolic control, and wi
th psychosocial variables: satisfaction with medical care, perceived stress
, social support, knowledge of diabetes and belief in conventional medicine
.
Methods We studied 160 patients in a cross-sectional design, in two groups:
with (70) and without social security coverage (90). The mean age for the
total group was 53.6 years, with a known diabetes duration of 8.1 years.
Results Denial of disease was similar in those with less than or equal to 5
years since diagnosis (73 patients) and with > 5 years (87). The group wit
hout social security had higher scores of perceived stress, and lower score
s of social support, knowledge about diabetes and belief in conventional me
dicine; denial, however, was similar in the two groups with or without soci
al security. Multiple regression analysis showed that denial of disease was
positively associated with HbA(1c) in the total group (P < 0.001), in the
groups with less than or equal to 5 and > 5 years since diagnosis, as well
as in the groups with or without social security. Denial was also associate
d with years since diagnosis (P = 0.009) for the group with less than or eq
ual to 5 years since diagnosis.
Conclusions We concluded that, in patients with Type 2 DM denial of disease
increases with time during the first 5 years of evolution of diabetes; is
associated with poor metabolic control; but is not associated with knowledg
e of diabetes, belief in conventional medicine, social support or perceived
stress.